Chief Scientific Officer · AtriCure, Inc. (ATRC)

Vinayak Doraiswamy

FY2021 is the first fiscal year CompBrief holds for Vinayak Doraiswamy as a named executive officer of AtriCure; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,696,606

Salary $393,600Stock awards $997,666

5th of 5 named executive officers at AtriCure by FY2021 total.

5 named officers on file for AtriCure, FY2021

Vinayak Doraiswamy’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • ATRC’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AtriCure’s whole pay program stands against its peers

  • AtriCure’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ATRC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 11, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Vinayak Doraiswamy’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Vinayak Doraiswamy compensation by year

AtriCure Summary Compensation Table · the one fiscal year held
In US dollars, as AtriCure reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$393,600
Bonus$0
Stock awards$997,666
Option awards$0
Non-equity incentive$296,640
Pension and deferred compensation$0
All other$8,700
Total$1,696,606

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AtriCure, Inc. DEF 14A filed April 11, 2022, accession 0001323885-22-000041, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AtriCure, Inc. filed document, accession 0001323885-22-000041. Every figure is read from that document and cited to the page and table it appears in. Filed April 11, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
PSU8,459$588,154—
PSU7,789$541,569—
PSU6,409$445,618—
RSU6,409$445,618—
RSU5,639$392,080—
RSU3,520$244,746—

Per the Outstanding Equity Awards at Fiscal Year-End table in AtriCure, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

21 Form 4 lines since the FY2021 proxy (filed April 11, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-07-28Sale—6,000$38.8886,511
2026-06-30Grant or award—636$23.7892,511
2026-05-15Sale—5,000$28.1391,875
2026-03-12Sale—5,000$29.8396,875
2026-03-01Grant or award—30,390$0.00102,262
2026-03-01Grant or award—15,198$0.00117,460
2026-03-01Tax withholding—15,585$31.26101,875
2025-08-05Sale—2,500$36.5871,872

The 8 most recent of 21 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

AtriCure’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Michael CarrelPresident and Chief Executive Officer$7,535,074
Douglas SeithChief Operating Officer$3,221,188
Angela WirickChief Financial Officer$1,955,292
Justin NozneskyChief Marketing and Strategy Officer$1,698,404
Vinayak Doraiswamy · this pageChief Scientific Officer$1,696,606

The full AtriCure compensation record

free company brief

This page is one person within AtriCure's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the AtriCure proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AtriCure's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Vinayak Doraiswamy's compensation dossier · One-time report. No refunds.